Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311128384> ?p ?o ?g. }
- W4311128384 abstract "Breast cancer (BC) is caused by epigenetic modifications and genetic heterogeneity and exhibits various histological feature. HER2+ (Human epidermal growth factor receptor 2) is a more aggressive type of breast cancer, diagnosis and prognosis are difficult for HER2+ BC. Anti-HER2+ inhibitors have been effectively used for patient treatment. High mortality rate is reported in HER2+ BC, due to availability of limited therapeutic options. Despite advances in systemic medications to treat metastatic breast cancer (MBC), HER2-positive MBC is still challenging for patients and treating clinicians. The clinical characteristics of the disease have changed after treatment with HER2-targeted therapy. Various types of Tyrosine kinase inhibitors (TKIs) have been developed to treat patients with HER2+ BC including afatinib, lapatinib, neratinib, tucatinib, and pyrotinib, have been developed as HER2-targeted therapies. The antibody-drug conjugates adotrastuzumab, emtansine, famtrastuzumab, and deruxtecan, as well as the anti-HER2 monoclonal antibody pertuzumab are used in both early-stage and metastatic situations, either alone or in conjunction with chemotherapy and other HER2-targeting therapies. The emergence of drug resistance in anti-HER2 therapies has been observed. To overcome drug resistance and limited efficacy in current treatment options, nano formulations can be used in patients with HER2+ BC treatment. Anti-HER2 ligands can be used in various nano formulations to target HER2 receptors. Here we will discuss, targeted TKIs in patients with HER2+ BC, clinical studies of HER2+ targeted TKIs, mechanisms of resistance to HER2-directed therapies with new implications of TKIs in HER2+ MBC (metastatic breast cancer) and anti-HER2 ligand in various nano formulations to target HER2 receptors." @default.
- W4311128384 created "2022-12-23" @default.
- W4311128384 creator A5049679012 @default.
- W4311128384 creator A5055609480 @default.
- W4311128384 creator A5071727338 @default.
- W4311128384 date "2022-12-12" @default.
- W4311128384 modified "2023-09-26" @default.
- W4311128384 title "Clinical updates on tyrosine kinase inhibitors in HER2-positive breast cancer" @default.
- W4311128384 cites W1760363395 @default.
- W4311128384 cites W1990010967 @default.
- W4311128384 cites W2003867647 @default.
- W4311128384 cites W2017693082 @default.
- W4311128384 cites W2024611216 @default.
- W4311128384 cites W2031240327 @default.
- W4311128384 cites W2075318716 @default.
- W4311128384 cites W2093143656 @default.
- W4311128384 cites W2096934656 @default.
- W4311128384 cites W2103931447 @default.
- W4311128384 cites W2111578514 @default.
- W4311128384 cites W2121862563 @default.
- W4311128384 cites W2138617860 @default.
- W4311128384 cites W2146208722 @default.
- W4311128384 cites W2159186230 @default.
- W4311128384 cites W2159967578 @default.
- W4311128384 cites W2269332562 @default.
- W4311128384 cites W2338611117 @default.
- W4311128384 cites W2412955216 @default.
- W4311128384 cites W2473406553 @default.
- W4311128384 cites W2484071785 @default.
- W4311128384 cites W2489099620 @default.
- W4311128384 cites W2510181658 @default.
- W4311128384 cites W2512471417 @default.
- W4311128384 cites W2520018761 @default.
- W4311128384 cites W2520273198 @default.
- W4311128384 cites W2527710791 @default.
- W4311128384 cites W2557509406 @default.
- W4311128384 cites W2559323428 @default.
- W4311128384 cites W2560406314 @default.
- W4311128384 cites W2584922809 @default.
- W4311128384 cites W2616596696 @default.
- W4311128384 cites W2625801680 @default.
- W4311128384 cites W2635415917 @default.
- W4311128384 cites W2745482862 @default.
- W4311128384 cites W2766722802 @default.
- W4311128384 cites W2768778626 @default.
- W4311128384 cites W2768980003 @default.
- W4311128384 cites W2783231346 @default.
- W4311128384 cites W2794930605 @default.
- W4311128384 cites W2795353688 @default.
- W4311128384 cites W2797623003 @default.
- W4311128384 cites W2800084163 @default.
- W4311128384 cites W2806074020 @default.
- W4311128384 cites W2806589295 @default.
- W4311128384 cites W2886263444 @default.
- W4311128384 cites W2890167612 @default.
- W4311128384 cites W2900390128 @default.
- W4311128384 cites W2908658437 @default.
- W4311128384 cites W2912993657 @default.
- W4311128384 cites W2922684335 @default.
- W4311128384 cites W2923042525 @default.
- W4311128384 cites W2943699531 @default.
- W4311128384 cites W2944883972 @default.
- W4311128384 cites W2947811794 @default.
- W4311128384 cites W2950243358 @default.
- W4311128384 cites W2970204123 @default.
- W4311128384 cites W2972399366 @default.
- W4311128384 cites W2982496779 @default.
- W4311128384 cites W2988134040 @default.
- W4311128384 cites W2994601580 @default.
- W4311128384 cites W2996968570 @default.
- W4311128384 cites W2997614825 @default.
- W4311128384 cites W3008323409 @default.
- W4311128384 cites W3009593680 @default.
- W4311128384 cites W3010393284 @default.
- W4311128384 cites W3011469361 @default.
- W4311128384 cites W3021570777 @default.
- W4311128384 cites W3030461309 @default.
- W4311128384 cites W3039853672 @default.
- W4311128384 cites W3042116371 @default.
- W4311128384 cites W3045656459 @default.
- W4311128384 cites W3049108467 @default.
- W4311128384 cites W3057398436 @default.
- W4311128384 cites W3081020835 @default.
- W4311128384 cites W3096687623 @default.
- W4311128384 cites W3103794344 @default.
- W4311128384 cites W3105660684 @default.
- W4311128384 cites W3106005610 @default.
- W4311128384 cites W3116476506 @default.
- W4311128384 cites W3117303512 @default.
- W4311128384 cites W3146093553 @default.
- W4311128384 cites W3158736337 @default.
- W4311128384 cites W3158772821 @default.
- W4311128384 cites W3161634313 @default.
- W4311128384 cites W3164577482 @default.
- W4311128384 cites W3171377332 @default.
- W4311128384 cites W3171617692 @default.
- W4311128384 cites W3192940245 @default.
- W4311128384 cites W3196044256 @default.
- W4311128384 cites W3200396260 @default.
- W4311128384 cites W3204825756 @default.